# Verva Pharmaceuticals

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/verva-pharmaceuticals

- Industry: Pharmaceuticals
- Headquarters: Melbourne, Australia
- Website: www.vervapharma.com
- Total disclosed funding: $3.8M
- Latest round: Series A (May 13, 2011)
- Investors on record: 4

## About

Founded in 2007 and based in Melbourne, Australia, Verva Pharmaceuticals Ltd. is a clinical-stage pharmaceutical company developing innovative therapies to treat metabolic diseases. The firm was formed from the merger of Autogen Research Ltd. (formerly the diabetes-focused subsidiary of ChemGenex Pharmaceuticals) and Adipogen Pharmaceuticals Pty Ltd

## Funding rounds

- Series A, May 13, 2011, $2.2M — GBS Venture Partners, Uniseed, QIC
- Series A, Jun 17, 2009, $1.6M — GBS Venture Partners, Uniseed, QIC, Westscheme Pty. Ltd.

## Investors

- GBS Venture Partners (https://capitalatlas.ai/funds/gbs-venture-partners) — Series A
- Uniseed (https://capitalatlas.ai/funds/uniseed) — Series A
- QIC (https://capitalatlas.ai/funds/qic) — Series A
- Westscheme Pty. Ltd. — Series A